Cargando…

Medicare Part D: Good for Patients and an Opportunity for Pharmacists

Detalles Bibliográficos
Autores principales:	Benner, Joshua S., Kocot, S. Lawrence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2009
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438342/ https://www.ncbi.nlm.nih.gov/pubmed/19125552 http://dx.doi.org/10.18553/jmcp.2009.15.1.66

Ejemplares similares

A Bleak Future for Independent Community Pharmacy Under Medicare Part D
por: Spooner, Joshua J.
Publicado: (2008)

Regional Variation in Pharmacist Perception of the Financial Impact of Medicare Part D
por: Khan, Shamima, et al.
Publicado: (2018)

Medicare Part D: Selected Issues for Pharmacists and Beneficiaries in 2007
por: Kilian, Janet, et al.
Publicado: (2007)

Medicare Part D: Selected Issues for Plan Sponsors, Pharmacists, and Beneficiaries in 2008
por: DePue, Ronnie, et al.
Publicado: (2008)

Insulin Pump Therapy Training and Management: An Opportunity for Community Pharmacists
por: Boyd, LeAnn C., et al.
Publicado: (2008)

Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement
por: Facciolo, Federico, et al.
Publicado: (2021)

Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development
por: Morrow, Norman C
Publicado: (2015)

Clinical Pharmacists: An Invaluable Part of the Coronavirus Disease 2019 Frontline Response
por: Ferguson, Nadia C., et al.
Publicado: (2020)

Medicare Part D on the Front Line
por: Collins, Andrew
Publicado: (2006)

The transition to universal health coverage in low and middle-income countries: new opportunities for community pharmacists
por: Naidoo, Vivian, et al.
Publicado: (2020)

Public Health Genomics: the essential part for good governance in public health
por: Brand, Angela, et al.
Publicado: (2016)

Current practices, gaps, and opportunities on the role of clinical pharmacists in cancer pain management: Perspectives from Nepal
por: Shrestha, Sunil, et al.
Publicado: (2023)

The Challenge of Medicare Part D for Community Pharmacies
por: Stone, Devin
Publicado: (2009)

Lessons for Medicare Part D in the hemodialysis community
por: Nayeem, Anisa I, et al.
Publicado: (2006)

Coverage of New Drugs in Medicare Part D
por: NACI, HUSEYIN, et al.
Publicado: (2022)

Comparison of Pharmacist and Physician Managed Annual Medicare Wellness Services
por: Sewell, Mary Jean, et al.
Publicado: (2016)

The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
por: Carvalho, Natalie, et al.
Publicado: (2019)

Commentary: Good surgery gets good results: Not so good if your patient is anemic
por: Kramer, Robert S.
Publicado: (2021)

Educational Approach to Increase Student Pharmacist Confidence with Medicare
por: Irwin, Adriane N
Publicado: (2021)

Pharmacists in Critical Care
por: Mohiuddin, AK
Publicado: (2019)

Pharmacists and COVID-19
por: Elbeddini, Ali, et al.
Publicado: (2020)

The New Era of Pharmacists in Ambulatory Patient Care
por: Mohiuddin, AK
Publicado: (2019)

Visualizing nationwide variation in medicare Part D prescribing patterns
por: Rosenberg, Alexander, et al.
Publicado: (2018)

The influence of Medicare Part D on the list pricing of brand drugs
por: Ippolito, Benedic N., et al.
Publicado: (2023)

The International Pharmacists-as-Immunizers Partnership (IPIP)—Advancing Research on Pharmacist-Administered Immunizations Worldwide
por: Violette, Richard R., et al.
Publicado: (2019)

Medicare Influence on Private Insurance: Good or Ill?
por: Jones, Stanley B.
Publicado: (1996)

Quality of care: how good is good enough?
por: Chassin, Mark R
Publicado: (2012)

Patient Experiences in Selecting a Medicare Part D Prescription Drug Plan
por: Stults, Cheryl D, et al.
Publicado: (2017)

Erratum to: The New Era of Pharmacists in Ambulatory Patient Care
por: Mohiuddin, AK
Publicado: (2020)

Pharmacists and Contraception in the Inpatient Setting
por: Ciriello, Domenique, et al.
Publicado: (2020)

Erratum to: Pharmacists in Critical Care
por: Mohiuddin, AK
Publicado: (2020)

Mandatory vaccination: understanding the common good in the midst of the global polio eradication campaign
por: Gostin, Lawrence O.
Publicado: (2018)

The Critical Need for Pharmacist Involvement in the Management of Patients With Hepatitis C
por: Spooner, Linda M
Publicado: (2009)

Medicare Part D—A Roundtable Discussion of Current Issues and Trends
por: Balfour, Donald, et al.
Publicado: (2009)

Correlation of antimicrobial prescription rate and county income in medicare part D
por: Volpi, Connor, et al.
Publicado: (2019)

Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program
por: Socal, Mariana P., et al.
Publicado: (2021)

Association of Out-of-Pocket Spending With Insulin Adherence in Medicare Part D
por: Trish, Erin, et al.
Publicado: (2021)

Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D
por: Naci, Huseyin, et al.
Publicado: (2023)

Erectile Dysfunction Medication Use in Veterans Eligible for Medicare Part D
por: Spencer, Samantha H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bc3p8u2ij1bjp6dhbogob57lk5